Trials / Completed
CompletedNCT02734706
Efficacy of a LRC™ (L. Reuteri NCIMB 30242) Capsule on Managing Cholesterol in Adults
Efficacy of a Supplement Capsule Containing LRC™ (L. Reuteri NCIMB 30242) on Managing Cholesterol Levels in Adults
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 111 (actual)
- Sponsor
- UAS Labs LLC · Industry
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the effect of a supplement capsule containing LRC™ (L. reuteri NCIMB 30242), taken twice daily with lunch and dinner (NLT 2.5E9 CFU per dose), versus placebo capsule on serum low density lipoprotein (LDL)-cholesterol in otherwise healthy hypercholesterolemic adults after 9 weeks of product consumption.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | LRC™ capsule | Twice per day (BID), 9 weeks |
| OTHER | Placebo capsule | Twice per day (BID), 9 weeks |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2018-11-01
- Completion
- 2019-02-01
- First posted
- 2016-04-12
- Last updated
- 2019-05-10
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02734706. Inclusion in this directory is not an endorsement.